Potrebujeme váš súhlas na využitie jednotlivých dát, aby sa vám okrem iného mohli ukazovať informácie týkajúce sa vašich záujmov. Súhlas udelíte kliknutím na tlačidlo „OK“.
Standard Specification for High Purity Calcium Sulfate Hemihydrate or Dihydrate for Surgical Implants
Automaticky preložený názov:
Štandard Specification pre High Purity polohydrát síranu vápenatého dihydrátu alebo na chirurgických implantátov
NORMA vydaná dňa 1.3.2014
Označenie normy: ASTM F2224-09(2014)
Poznámka: NEPLATNÁ
Dátum vydania normy: 1.3.2014
Kód tovaru: NS-53256
Počet strán: 4
Približná hmotnosť: 12 g (0.03 libier)
Krajina: Americká technická norma
Kategória: Technické normy ASTM
Keywords:
bone, calcium sulfate, gypsum, implant, plaster, ICS Number Code 11.040.40 (Implants for surgery, prothetics and orthotics)
1. Scope | ||||||||||||||||||||
1.1 This specification covers material requirements for unfabricated and fabricated forms of hydrated calcium sulfate intended for surgical implants. Fabricated forms may include pressed and cast surgical implants in various geometric shapes. The calcium sulfate hemihydrate in the unfabricated form can be converted with the addition of water or other water-containing solutions to a fabricated calcium sulfate dihydrate form. 1.2 The requirements of this specification apply to calcium sulfate combined with two molecules of water or two calcium sulfate molecules sharing one water molecule. Approximate chemical formulae:
1.3 This specification specifically excludes calcium sulfate anhydrite and calcium sulfate forms that contain additives such as reinforcing phases, medicaments, biological agents, and so forth. 1.4 The presence of processing aids does not exclude a product from the physical and mechanical requirements of this specification. 1.5 Some provisions of Specification C59/C59M and Test Methods C472 apply. Special requirements that are detailed in this specification are included to characterize the material which will be used in surgical implants. 1.6 The biological response to calcium sulfate in bone tissue has been well characterized by a history of clinical use (1-14)2 and by laboratory studies (15-18). 1.7 The following precautionary caveat pertains only to the test method portion, Sections 4, 5, and 6, of this specification. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use. |
||||||||||||||||||||
2. Referenced Documents | ||||||||||||||||||||
|
Historická
15.8.2013
Historická
1.4.2014
Historická
1.6.2013
Historická
1.12.2013
Historická
1.2.2014
Historická
1.4.2013
Chcete mať istotu, že používate len platné technické normy?
Ponúkame Vám riešenie, ktoré Vám zaistí mesačný prehľad o aktuálnosti noriem, ktoré používate.
Chcete vedieť viac informácií ? Pozrite sa na túto stránku.
Posledná aktualizácia: 2024-11-22 (Počet položiek: 2 206 568)
© Copyright 2024 NORMSERVIS s.r.o.